COMPASS is a mental health care company dedicated to accelerating patient access to evidencebased innovation in mental health. In is role, Kabir will continue building on COMPASS’ success and work advancing patient access to evidence-based, technology-enabled innovative care models, combining pharmacological, psychological, and digital solutions.

George Goldsmith, current CEO and Chairman of COMPASS Pathways, said: “We founded COMPASS Pathways to transform mental health care by creating a personalised, predictive and preventative model of care. As we enter the next stage of development, Kabir brings a track record of successful strategic growth, and a deep dedication to this mission.

“Working alongside our talented leadership team, he will leverage his extensive background in leading the commercialisation of innovative therapies to bring COMP360 psilocybin therapy to the large number of patients who are not currently being helped by existing treatments.”